Pfizer and Strata expand clinical partnership for cancer trial

Pfizer and Strata Oncology have expanded their partnership for a clinical trial assessing various cancer therapies in new, biomarker-guided patient groups.

Named Strata Precision Indications for Approved THerapies (Strata PATH), the prospective, pan-tumour therapeutic trial is designed to assess the safety and efficacy of various cancer therapies in these subjects.